pharmacor sitagliptin sitagliptin 25 mg film-coated tablet bottle
pharmacor pty ltd - sitagliptin hydrochloride monohydrate, quantity: 27.25 mg (equivalent: sitagliptin, qty 25 mg) - tablet, film coated - excipient ingredients: sodium stearylfumarate; croscarmellose sodium; povidone; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; magnesium stearate; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - pharmacor sitagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as:,- monotherapy when metformin is considered inappropriate due to intolerance; or,- in combination with other anti-hyperglycaemic agents, including insulin,[see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies].
sitaglo sitagliptin 100 mg film-coated tablet blister pack
pharmacor pty ltd - sitagliptin hydrochloride monohydrate, quantity: 109 mg (equivalent: sitagliptin, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; sodium stearylfumarate; povidone; calcium hydrogen phosphate dihydrate; croscarmellose sodium; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - sitaglo is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as:,- monotherapy when metformin is considered inappropriate due to intolerance; or,- in combination with other anti-hyperglycaemic agents, including insulin,[see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies].
pharmacor sitagliptin sitagliptin 100 mg film-coated tablet bottle
pharmacor pty ltd - sitagliptin hydrochloride monohydrate, quantity: 109 mg (equivalent: sitagliptin, qty 100 mg) - tablet, film coated - excipient ingredients: sodium stearylfumarate; magnesium stearate; povidone; croscarmellose sodium; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - pharmacor sitagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as:,- monotherapy when metformin is considered inappropriate due to intolerance; or,- in combination with other anti-hyperglycaemic agents, including insulin,[see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies].
steglatro 5mg film-coated tablets
merck sharp & dohme (malaysia) sdn bhd - ertugliflozin l-pyroglutamic acid -
steglatro 15mg film-coated tablets
merck sharp & dohme (malaysia) sdn bhd - ertugliflozin l-pyroglutamic acid -
steglujan tablet
merck canada inc - ertugliflozin; sitagliptin (sitagliptin phosphate) - tablet - 5mg; 100mg - ertugliflozin 5mg; sitagliptin (sitagliptin phosphate) 100mg - dipeptidyl peptidase-4 (dpp-4) inhibitors
steglujan tablet
merck canada inc - ertugliflozin; sitagliptin (sitagliptin phosphate) - tablet - 15mg; 100mg - ertugliflozin 15mg; sitagliptin (sitagliptin phosphate) 100mg - dipeptidyl peptidase-4 (dpp-4) inhibitors
steglatro 5 mg/1 tab
مستودع أدوية أداتكو - adatco drug store - ertugliflozin 5 mg/1 tab - 5 mg/1 tab
steglatro 15 mg/1 tab
مستودع أدوية أداتكو - adatco drug store - ertugliflozin 15 mg/1 tab - 15 mg/1 tab
steglujan film-coated tablets 15mg100mg
msd pharma (singapore) pte. ltd. - ertugliflozin l-pga eqv to ertugliflozin; sitagliptin phosphate monohydrate eqv to sitagliptin - tablet, film coated - ertugliflozin l-pga eqv to ertugliflozin 15mg; sitagliptin phosphate monohydrate eqv to sitagliptin 100mg